Hims & Hers reports 111% YoY sales growth & 70%+ gross margin. Discover their growth potential, risks, & why it's a Buy ...

First Quarter 2025 Results Key Financial Results Revenue: US$586.0m (up 111% from ...

Hims & Hers Health (NYSE:HIMS) reported first-quarter earnings on Monday after the market closed and rocketed 18% after ...

Q1 2025 Earnings Call Transcript May 5, 2025 Hims & Hers Health, Inc. beats earnings expectations. Reported EPS is $0.2, expectations were $0.12. Operator: Good afternoon, ladies and gentlemen. Thank ...

We recently published a list of Here’s What Fueled These 10 Firms’ Surge. In this article, we are going to take a look at ...

Hims & Hers (NYSE: HIMS) stock soared 18.2% in trading on Tuesday after the company reported first-quarter revenue growth of 111% and an increase in 2025 guidance. The results were phenomenal and a ...

Novo Nordisk shares rose after the Danish obesity-drug maker's first-quarter earnings topped Wall Street expectations. As widely anticipated, the drug maker reduced its growth forecast to reflect the ...

Novo Nordisk reports its results in Danish kroner (DKK) rather than U.S. dollars. Sales grew 19% year over year to 78.1 ...

OMAHA, Neb., April 28, 2025--Green Plains Inc. (NASDAQ:GPRE) will release first quarter 2025 financial results prior to the market opening on May 8, 2025, and then host a conference call beginning ...